Intended for healthcare professionals

News

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots

BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n699 (Published 11 March 2021) Cite this as: BMJ 2021;372:n699

Read our latest coverage of the coronavirus outbreak

  1. Jacqui Wise
  1. London

Denmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots and one death. However, the European Medicines Agency (EMA) and the UK’s regulatory body have said that there is no indication that vaccination is linked to thromboembolic events.

Eight other countries—Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, Italy, and Latvia—have also suspended use of AstraZeneca’s vaccine. The decisions are a further setback for Europe’s vaccination campaign, which has struggled to pick up speed, partly because of delays in delivering the AstraZeneca vaccine.

The Danish Health Authority said that one person in Denmark had died after receiving the AstraZeneca vaccine and that it would suspend the drug’s use for two weeks while the case was investigated. “It is important to point out that we have not terminated the use of the AstraZeneca vaccine—we are just pausing its use,” said the Danish Health Authority’s director, Soren Brostrøm.

On 10 …

View Full Text